nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MUT—cardiac ventricle—dilated cardiomyopathy	0.02	0.083	CbGeAlD
Hydroxocobalamin—MMAA—heart—dilated cardiomyopathy	0.0195	0.081	CbGeAlD
Hydroxocobalamin—Bullous eruption—Furosemide—dilated cardiomyopathy	0.0194	0.0631	CcSEcCtD
Hydroxocobalamin—MUT—myocardium—dilated cardiomyopathy	0.0188	0.078	CbGeAlD
Hydroxocobalamin—MMAB—heart—dilated cardiomyopathy	0.0183	0.076	CbGeAlD
Hydroxocobalamin—MTRR—cardiac ventricle—dilated cardiomyopathy	0.018	0.0745	CbGeAlD
Hydroxocobalamin—CASP9—heart—dilated cardiomyopathy	0.0171	0.071	CbGeAlD
Hydroxocobalamin—MTRR—myocardium—dilated cardiomyopathy	0.0169	0.0701	CbGeAlD
Hydroxocobalamin—TCN2—heart—dilated cardiomyopathy	0.0167	0.0693	CbGeAlD
Hydroxocobalamin—MTR—cardiac ventricle—dilated cardiomyopathy	0.0157	0.065	CbGeAlD
Hydroxocobalamin—MTR—myocardium—dilated cardiomyopathy	0.0147	0.0612	CbGeAlD
Hydroxocobalamin—MUT—heart—dilated cardiomyopathy	0.0131	0.0545	CbGeAlD
Hydroxocobalamin—MTRR—heart—dilated cardiomyopathy	0.0118	0.0489	CbGeAlD
Hydroxocobalamin—MUT—cardiac atrium—dilated cardiomyopathy	0.0112	0.0466	CbGeAlD
Hydroxocobalamin—Thrombosis—Furosemide—dilated cardiomyopathy	0.0108	0.0353	CcSEcCtD
Hydroxocobalamin—MTR—heart—dilated cardiomyopathy	0.0103	0.0427	CbGeAlD
Hydroxocobalamin—MTRR—cardiac atrium—dilated cardiomyopathy	0.0101	0.0419	CbGeAlD
Hydroxocobalamin—Fluid overload—Lisinopril—dilated cardiomyopathy	0.00926	0.0301	CcSEcCtD
Hydroxocobalamin—MTR—cardiac atrium—dilated cardiomyopathy	0.0088	0.0365	CbGeAlD
Hydroxocobalamin—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00752	0.0244	CcSEcCtD
Hydroxocobalamin—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00734	0.0239	CcSEcCtD
Hydroxocobalamin—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00651	0.0212	CcSEcCtD
Hydroxocobalamin—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00637	0.0207	CcSEcCtD
Hydroxocobalamin—Swelling—Furosemide—dilated cardiomyopathy	0.00631	0.0205	CcSEcCtD
Hydroxocobalamin—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00583	0.019	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00572	0.0186	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00559	0.0182	CcSEcCtD
Hydroxocobalamin—Malaise—Spironolactone—dilated cardiomyopathy	0.00556	0.0181	CcSEcCtD
Hydroxocobalamin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00519	0.0169	CcSEcCtD
Hydroxocobalamin—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00512	0.0167	CcSEcCtD
Hydroxocobalamin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00507	0.0165	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00503	0.0164	CcSEcCtD
Hydroxocobalamin—Eczema—Lisinopril—dilated cardiomyopathy	0.00465	0.0151	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00434	0.0141	CcSEcCtD
Hydroxocobalamin—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.0042	0.0136	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00415	0.0135	CcSEcCtD
Hydroxocobalamin—Urticaria—Spironolactone—dilated cardiomyopathy	0.004	0.013	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00398	0.0129	CcSEcCtD
Hydroxocobalamin—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00397	0.0129	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00381	0.0124	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00378	0.0123	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00371	0.0121	CcSEcCtD
Hydroxocobalamin—Eye disorder—Furosemide—dilated cardiomyopathy	0.0036	0.0117	CcSEcCtD
Hydroxocobalamin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00356	0.0116	CcSEcCtD
Hydroxocobalamin—Angiopathy—Furosemide—dilated cardiomyopathy	0.0035	0.0114	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00348	0.0113	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00344	0.0112	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00344	0.0112	CcSEcCtD
Hydroxocobalamin—Erythema—Furosemide—dilated cardiomyopathy	0.00335	0.0109	CcSEcCtD
Hydroxocobalamin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00333	0.0108	CcSEcCtD
Hydroxocobalamin—Rash—Spironolactone—dilated cardiomyopathy	0.00317	0.0103	CcSEcCtD
Hydroxocobalamin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00317	0.0103	CcSEcCtD
Hydroxocobalamin—Headache—Spironolactone—dilated cardiomyopathy	0.00315	0.0103	CcSEcCtD
Hydroxocobalamin—Agitation—Furosemide—dilated cardiomyopathy	0.00308	0.01	CcSEcCtD
Hydroxocobalamin—Nausea—Spironolactone—dilated cardiomyopathy	0.00299	0.00972	CcSEcCtD
Hydroxocobalamin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00286	0.00928	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00285	0.00926	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00284	0.00922	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00283	0.00922	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00274	0.0089	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00268	0.00873	CcSEcCtD
Hydroxocobalamin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00266	0.00865	CcSEcCtD
Hydroxocobalamin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00262	0.00853	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00261	0.00847	CcSEcCtD
Hydroxocobalamin—Chills—Lisinopril—dilated cardiomyopathy	0.00259	0.00844	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00258	0.0084	CcSEcCtD
Hydroxocobalamin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00253	0.00824	CcSEcCtD
Hydroxocobalamin—Erythema—Lisinopril—dilated cardiomyopathy	0.00252	0.00818	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00236	0.00769	CcSEcCtD
Hydroxocobalamin—Pain—Furosemide—dilated cardiomyopathy	0.00234	0.00761	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00234	0.00759	CcSEcCtD
Hydroxocobalamin—MMACHC—Metabolism—TAZ—dilated cardiomyopathy	0.0023	0.0051	CbGpPWpGaD
Hydroxocobalamin—Angioedema—Lisinopril—dilated cardiomyopathy	0.0023	0.00748	CcSEcCtD
Hydroxocobalamin—Malaise—Lisinopril—dilated cardiomyopathy	0.00227	0.00738	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00226	0.00734	CcSEcCtD
Hydroxocobalamin—MUT—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.00225	0.00498	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—PSEN2—dilated cardiomyopathy	0.00224	0.00497	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—ANKRD1—dilated cardiomyopathy	0.00224	0.00496	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00224	0.00496	CbGpPWpGaD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.00221	0.0049	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—RAC1—dilated cardiomyopathy	0.0022	0.00487	CbGpPWpGaD
Hydroxocobalamin—CASP9—DNA Damage Response—FAS—dilated cardiomyopathy	0.00219	0.00485	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Furosemide—dilated cardiomyopathy	0.00217	0.00707	CcSEcCtD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—RAC1—dilated cardiomyopathy	0.00217	0.00481	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—IL10—dilated cardiomyopathy	0.00216	0.0048	CbGpPWpGaD
Hydroxocobalamin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00216	0.00704	CcSEcCtD
Hydroxocobalamin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00214	0.00697	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00213	0.00692	CcSEcCtD
Hydroxocobalamin—CASP9—p75(NTR)-mediated signaling—RAC1—dilated cardiomyopathy	0.00212	0.0047	CbGpPWpGaD
Hydroxocobalamin—MMAA—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00212	0.0047	CbGpPWpGaD
Hydroxocobalamin—Discomfort—Lisinopril—dilated cardiomyopathy	0.00212	0.00688	CcSEcCtD
Hydroxocobalamin—CASP9—miRNA Regulation of DNA Damage Response—FAS—dilated cardiomyopathy	0.00211	0.00468	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—TAZ—dilated cardiomyopathy	0.00211	0.00467	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—TAZ—dilated cardiomyopathy	0.00211	0.00467	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00208	0.00461	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—SDHA—dilated cardiomyopathy	0.00208	0.00461	CbGpPWpGaD
Hydroxocobalamin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00205	0.00668	CcSEcCtD
Hydroxocobalamin—Oedema—Lisinopril—dilated cardiomyopathy	0.00205	0.00668	CcSEcCtD
Hydroxocobalamin—Infection—Lisinopril—dilated cardiomyopathy	0.00204	0.00664	CcSEcCtD
Hydroxocobalamin—MUT—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00202	0.00448	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00202	0.00656	CcSEcCtD
Hydroxocobalamin—CASP9—Allograft Rejection—FASLG—dilated cardiomyopathy	0.00201	0.00446	CbGpPWpGaD
Hydroxocobalamin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.002	0.00652	CcSEcCtD
Hydroxocobalamin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.002	0.00649	CcSEcCtD
Hydroxocobalamin—TCN2—Metabolism—TAZ—dilated cardiomyopathy	0.00196	0.00434	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—FAS—dilated cardiomyopathy	0.00194	0.0043	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—FAS—dilated cardiomyopathy	0.00194	0.0043	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—LMNA—dilated cardiomyopathy	0.00194	0.00429	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Furosemide—dilated cardiomyopathy	0.00194	0.0063	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis—FASLG—dilated cardiomyopathy	0.00192	0.00425	CbGpPWpGaD
Hydroxocobalamin—MTRR—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00191	0.00422	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—SDHA—dilated cardiomyopathy	0.0019	0.00422	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—SDHA—dilated cardiomyopathy	0.0019	0.00422	CbGpPWpGaD
Hydroxocobalamin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00187	0.00609	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism—ANKRD1—dilated cardiomyopathy	0.00186	0.00411	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—ANKRD1—dilated cardiomyopathy	0.00186	0.00411	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—FAS—dilated cardiomyopathy	0.00185	0.00409	CbGpPWpGaD
Hydroxocobalamin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00183	0.00595	CcSEcCtD
Hydroxocobalamin—Dizziness—Furosemide—dilated cardiomyopathy	0.00181	0.00589	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00181	0.00588	CcSEcCtD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—FASLG—dilated cardiomyopathy	0.0018	0.00398	CbGpPWpGaD
Hydroxocobalamin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00177	0.00577	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—ANKRD1—dilated cardiomyopathy	0.00177	0.00392	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—SDHA—dilated cardiomyopathy	0.00177	0.00392	CbGpPWpGaD
Hydroxocobalamin—Pain—Lisinopril—dilated cardiomyopathy	0.00176	0.00571	CcSEcCtD
Hydroxocobalamin—AMN—Metabolism—TAZ—dilated cardiomyopathy	0.00175	0.00387	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—TAZ—dilated cardiomyopathy	0.00175	0.00387	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis Modulation and Signaling—FAS—dilated cardiomyopathy	0.00173	0.00384	CbGpPWpGaD
Hydroxocobalamin—Rash—Furosemide—dilated cardiomyopathy	0.00173	0.00561	CcSEcCtD
Hydroxocobalamin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00172	0.00561	CcSEcCtD
Hydroxocobalamin—Headache—Furosemide—dilated cardiomyopathy	0.00172	0.00558	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00169	0.0055	CcSEcCtD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.00168	0.00373	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—TAZ—dilated cardiomyopathy	0.00166	0.00369	CbGpPWpGaD
Hydroxocobalamin—CASP9—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—dilated cardiomyopathy	0.00166	0.00367	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ANKRD1—dilated cardiomyopathy	0.00163	0.00362	CbGpPWpGaD
Hydroxocobalamin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00163	0.00531	CcSEcCtD
Hydroxocobalamin—Nausea—Furosemide—dilated cardiomyopathy	0.00163	0.00529	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00162	0.00528	CcSEcCtD
Hydroxocobalamin—MMAA—Metabolism—SDHA—dilated cardiomyopathy	0.00158	0.0035	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—SDHA—dilated cardiomyopathy	0.00158	0.0035	CbGpPWpGaD
Hydroxocobalamin—MTR—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00155	0.00344	CbGpPWpGaD
Hydroxocobalamin—MTRR—Folate Metabolism—TNF—dilated cardiomyopathy	0.00155	0.00343	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—TAZ—dilated cardiomyopathy	0.00154	0.0034	CbGpPWpGaD
Hydroxocobalamin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00151	0.00492	CcSEcCtD
Hydroxocobalamin—MUT—Metabolism—SDHA—dilated cardiomyopathy	0.00151	0.00334	CbGpPWpGaD
Hydroxocobalamin—CASP9—Amyotrophic lateral sclerosis (ALS)—TNF—dilated cardiomyopathy	0.00148	0.00328	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.00146	0.00323	CbGpPWpGaD
Hydroxocobalamin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00145	0.00473	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00141	0.00457	CcSEcCtD
Hydroxocobalamin—CUBN—Metabolism—SDHA—dilated cardiomyopathy	0.00139	0.00308	CbGpPWpGaD
Hydroxocobalamin—CASP9—FAS pathway and Stress induction of HSP regulation—TNF—dilated cardiomyopathy	0.00137	0.00303	CbGpPWpGaD
Hydroxocobalamin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00136	0.00442	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.00135	0.003	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ANKRD1—dilated cardiomyopathy	0.00134	0.00297	CbGpPWpGaD
Hydroxocobalamin—Rash—Lisinopril—dilated cardiomyopathy	0.0013	0.00421	CcSEcCtD
Hydroxocobalamin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00129	0.00421	CcSEcCtD
Hydroxocobalamin—Headache—Lisinopril—dilated cardiomyopathy	0.00129	0.00418	CcSEcCtD
Hydroxocobalamin—MMACHC—Disease—NPPA—dilated cardiomyopathy	0.00127	0.00282	CbGpPWpGaD
Hydroxocobalamin—MTR—Folate Metabolism—TNF—dilated cardiomyopathy	0.00126	0.0028	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—TAZ—dilated cardiomyopathy	0.00126	0.0028	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—PSEN2—dilated cardiomyopathy	0.00123	0.00273	CbGpPWpGaD
Hydroxocobalamin—Nausea—Lisinopril—dilated cardiomyopathy	0.00122	0.00397	CcSEcCtD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—RAC1—dilated cardiomyopathy	0.0012	0.00265	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—FASLG—dilated cardiomyopathy	0.00117	0.0026	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—NPPA—dilated cardiomyopathy	0.00116	0.00258	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—NPPA—dilated cardiomyopathy	0.00116	0.00258	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—SDHA—dilated cardiomyopathy	0.00114	0.00253	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.00113	0.00251	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—FAS—dilated cardiomyopathy	0.00113	0.00251	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—PSEN2—dilated cardiomyopathy	0.00113	0.0025	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—PSEN2—dilated cardiomyopathy	0.00113	0.0025	CbGpPWpGaD
Hydroxocobalamin—CASP9—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.00112	0.00247	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.00112	0.00247	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	0.0011	0.00244	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ANKRD1—dilated cardiomyopathy	0.00109	0.00242	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—NPPA—dilated cardiomyopathy	0.00108	0.0024	CbGpPWpGaD
Hydroxocobalamin—CASP9—Caspase Cascade in Apoptosis—TNF—dilated cardiomyopathy	0.00107	0.00237	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.00106	0.00235	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—RAC1—dilated cardiomyopathy	0.00106	0.00235	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—PSEN2—dilated cardiomyopathy	0.00105	0.00232	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	0.00104	0.00231	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—TAZ—dilated cardiomyopathy	0.00103	0.00228	CbGpPWpGaD
Hydroxocobalamin—MTR—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.001	0.00222	CbGpPWpGaD
Hydroxocobalamin—CASP9—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000999	0.00221	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.000998	0.00221	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—RAC1—dilated cardiomyopathy	0.000998	0.00221	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000993	0.0022	CbGpPWpGaD
Hydroxocobalamin—CASP9—Rac1/Pak1/p38/MMP-2 pathway—EGFR—dilated cardiomyopathy	0.000987	0.00219	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—NPPA—dilated cardiomyopathy	0.000965	0.00214	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—NPPA—dilated cardiomyopathy	0.000965	0.00214	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000963	0.00213	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000963	0.00213	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000958	0.00212	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000939	0.00208	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000938	0.00208	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000938	0.00208	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—PSEN2—dilated cardiomyopathy	0.000934	0.00207	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—PSEN2—dilated cardiomyopathy	0.000934	0.00207	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—SDHA—dilated cardiomyopathy	0.00093	0.00206	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—NPPA—dilated cardiomyopathy	0.00092	0.00204	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000918	0.00203	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000894	0.00198	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—PSEN2—dilated cardiomyopathy	0.000891	0.00198	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—NPPA—dilated cardiomyopathy	0.000849	0.00188	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000848	0.00188	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000844	0.00187	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000844	0.00187	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000825	0.00183	CbGpPWpGaD
Hydroxocobalamin—CASP9—Alzheimers Disease—TNF—dilated cardiomyopathy	0.000824	0.00183	CbGpPWpGaD
Hydroxocobalamin—CASP9—Allograft Rejection—TNF—dilated cardiomyopathy	0.000824	0.00183	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PSEN2—dilated cardiomyopathy	0.000823	0.00182	CbGpPWpGaD
Hydroxocobalamin—CASP9—Constitutive PI3K/AKT Signaling in Cancer—EGFR—dilated cardiomyopathy	0.000808	0.00179	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000805	0.00178	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—RAF1—dilated cardiomyopathy	0.000794	0.00176	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TNF—dilated cardiomyopathy	0.000784	0.00174	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—RAF1—dilated cardiomyopathy	0.000759	0.00168	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—RAF1—dilated cardiomyopathy	0.000747	0.00166	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000743	0.00165	CbGpPWpGaD
Hydroxocobalamin—CASP9—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.000729	0.00162	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI-3K cascade—EGFR—dilated cardiomyopathy	0.000728	0.00161	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—RAF1—dilated cardiomyopathy	0.000714	0.00158	CbGpPWpGaD
Hydroxocobalamin—CASP9—PI3K/AKT activation—EGFR—dilated cardiomyopathy	0.000711	0.00157	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—RAF1—dilated cardiomyopathy	0.00071	0.00157	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—RAF1—dilated cardiomyopathy	0.000707	0.00157	CbGpPWpGaD
Hydroxocobalamin—CASP9—GAB1 signalosome—EGFR—dilated cardiomyopathy	0.000705	0.00156	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—RAF1—dilated cardiomyopathy	0.000703	0.00156	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NPPA—dilated cardiomyopathy	0.000698	0.00155	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.00069	0.00153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—dilated cardiomyopathy	0.000689	0.00153	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—RAC1—dilated cardiomyopathy	0.00068	0.00151	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PSEN2—dilated cardiomyopathy	0.000676	0.0015	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	0.000662	0.00147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—RAF1—dilated cardiomyopathy	0.000662	0.00147	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—RAF1—dilated cardiomyopathy	0.000662	0.00147	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—RAF1—dilated cardiomyopathy	0.000656	0.00145	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—RAF1—dilated cardiomyopathy	0.00065	0.00144	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—RAF1—dilated cardiomyopathy	0.000647	0.00143	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000623	0.00138	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—RAC1—dilated cardiomyopathy	0.00062	0.00137	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000586	0.0013	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NPPA—dilated cardiomyopathy	0.000569	0.00126	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—RAC1—dilated cardiomyopathy	0.000567	0.00126	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—RAC1—dilated cardiomyopathy	0.000567	0.00126	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—GPX1—dilated cardiomyopathy	0.000566	0.00125	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—CD36—dilated cardiomyopathy	0.000551	0.00122	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PSEN2—dilated cardiomyopathy	0.000551	0.00122	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by SCF-KIT—EGFR—dilated cardiomyopathy	0.000544	0.00121	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—RAC1—dilated cardiomyopathy	0.000527	0.00117	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling of activated FGFR—EGFR—dilated cardiomyopathy	0.000521	0.00115	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—GPX1—dilated cardiomyopathy	0.000517	0.00115	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—GPX1—dilated cardiomyopathy	0.000517	0.00115	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	0.000515	0.00114	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB4—EGFR—dilated cardiomyopathy	0.000513	0.00114	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—CD36—dilated cardiomyopathy	0.000504	0.00112	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—CD36—dilated cardiomyopathy	0.000504	0.00112	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AGT—dilated cardiomyopathy	0.000496	0.0011	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signal transduction—EGFR—dilated cardiomyopathy	0.000489	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR—EGFR—dilated cardiomyopathy	0.000487	0.00108	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by ERBB2—EGFR—dilated cardiomyopathy	0.000485	0.00107	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 signaling—EGFR—dilated cardiomyopathy	0.000482	0.00107	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—GPX1—dilated cardiomyopathy	0.000481	0.00107	CbGpPWpGaD
Hydroxocobalamin—CASP9—Apoptosis—TNF—dilated cardiomyopathy	0.000481	0.00106	CbGpPWpGaD
Hydroxocobalamin—CASP9—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000475	0.00105	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	0.000473	0.00105	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—RAC1—dilated cardiomyopathy	0.00047	0.00104	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—RAC1—dilated cardiomyopathy	0.00047	0.00104	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—CD36—dilated cardiomyopathy	0.000469	0.00104	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000463	0.00103	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AGT—dilated cardiomyopathy	0.000454	0.00101	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AGT—dilated cardiomyopathy	0.000454	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	0.000454	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	0.000454	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—DAP12 interactions—EGFR—dilated cardiomyopathy	0.000454	0.00101	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000451	0.000999	CbGpPWpGaD
Hydroxocobalamin—CASP9—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	0.000451	0.000998	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR—EGFR—dilated cardiomyopathy	0.00045	0.000996	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—RAC1—dilated cardiomyopathy	0.000448	0.000993	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	0.000446	0.000987	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by PDGF—EGFR—dilated cardiomyopathy	0.000444	0.000983	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—GPX1—dilated cardiomyopathy	0.000429	0.00095	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—GPX1—dilated cardiomyopathy	0.000429	0.00095	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NPPA—dilated cardiomyopathy	0.000428	0.000949	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000427	0.000946	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AGT—dilated cardiomyopathy	0.000422	0.000935	CbGpPWpGaD
Hydroxocobalamin—CASP9—B Cell Activation—EGFR—dilated cardiomyopathy	0.00042	0.00093	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—CD36—dilated cardiomyopathy	0.000418	0.000925	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—CD36—dilated cardiomyopathy	0.000418	0.000925	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PSEN2—dilated cardiomyopathy	0.000415	0.000919	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—RAC1—dilated cardiomyopathy	0.000414	0.000917	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—CD36—dilated cardiomyopathy	0.000411	0.000912	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—RAF1—dilated cardiomyopathy	0.000411	0.000911	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—GPX1—dilated cardiomyopathy	0.000409	0.000906	CbGpPWpGaD
Hydroxocobalamin—CASP9—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000407	0.000901	CbGpPWpGaD
Hydroxocobalamin—CASP9—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000402	0.00089	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—CD36—dilated cardiomyopathy	0.000398	0.000883	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000395	0.000875	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—RAC1—dilated cardiomyopathy	0.000388	0.000859	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—GPX1—dilated cardiomyopathy	0.000377	0.000836	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—RAF1—dilated cardiomyopathy	0.000376	0.000833	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—RAF1—dilated cardiomyopathy	0.000376	0.000833	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AGT—dilated cardiomyopathy	0.000376	0.000833	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AGT—dilated cardiomyopathy	0.000376	0.000833	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000372	0.000825	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—CD36—dilated cardiomyopathy	0.000368	0.000815	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AGT—dilated cardiomyopathy	0.000359	0.000795	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—RAF1—dilated cardiomyopathy	0.00035	0.000774	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—RAC1—dilated cardiomyopathy	0.00034	0.000753	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AGT—dilated cardiomyopathy	0.000331	0.000733	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—RAF1—dilated cardiomyopathy	0.000312	0.00069	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—RAF1—dilated cardiomyopathy	0.000312	0.00069	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—GPX1—dilated cardiomyopathy	0.00031	0.000687	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000309	0.000685	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CD36—dilated cardiomyopathy	0.000302	0.000669	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—RAF1—dilated cardiomyopathy	0.000297	0.000659	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00029	0.000643	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—dilated cardiomyopathy	0.000282	0.000625	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ITGB1—dilated cardiomyopathy	0.000281	0.000622	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—RAC1—dilated cardiomyopathy	0.000277	0.000614	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—RAF1—dilated cardiomyopathy	0.000274	0.000608	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AGT—dilated cardiomyopathy	0.000272	0.000602	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—dilated cardiomyopathy	0.000258	0.000571	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—dilated cardiomyopathy	0.000258	0.000571	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000258	0.000571	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000258	0.000571	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—RAF1—dilated cardiomyopathy	0.000257	0.00057	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GPX1—dilated cardiomyopathy	0.000253	0.00056	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000247	0.000547	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CD36—dilated cardiomyopathy	0.000246	0.000545	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—dilated cardiomyopathy	0.00024	0.000531	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00024	0.000531	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD36—dilated cardiomyopathy	0.00024	0.000531	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000232	0.000514	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RAC1—dilated cardiomyopathy	0.000226	0.0005	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—RAF1—dilated cardiomyopathy	0.000225	0.000499	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AGT—dilated cardiomyopathy	0.000222	0.000491	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—dilated cardiomyopathy	0.000214	0.000473	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—dilated cardiomyopathy	0.000214	0.000473	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RAC1—dilated cardiomyopathy	0.000208	0.000462	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—dilated cardiomyopathy	0.000204	0.000452	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000198	0.000439	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—dilated cardiomyopathy	0.000188	0.000417	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000188	0.000417	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—RAF1—dilated cardiomyopathy	0.000184	0.000407	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—dilated cardiomyopathy	0.000176	0.000391	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000169	0.000375	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000162	0.000358	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—dilated cardiomyopathy	0.000154	0.000342	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RAF1—dilated cardiomyopathy	0.00015	0.000332	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000146	0.000323	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGT—dilated cardiomyopathy	0.000139	0.000309	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—RAF1—dilated cardiomyopathy	0.000138	0.000306	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—dilated cardiomyopathy	0.000126	0.000279	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—dilated cardiomyopathy	0.000103	0.000228	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RAF1—dilated cardiomyopathy	9.68e-05	0.000214	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—dilated cardiomyopathy	9.48e-05	0.00021	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—dilated cardiomyopathy	6.64e-05	0.000147	CbGpPWpGaD
